anti-HMGB1 monoclonal antibody (Abnova)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Nameanti-HMGB1 monoclonal antibody (Abnova)
Drug Alias Namefully human high-mobility group box-1-targeted monoclonal antibody (Abnova)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionHigh Mobility Group Protein B1 inhibitors
TargetsHigh Mobility Group Protein B1
Therapy Area/IndicationsInflammationNeoplasmsSepsis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAbnova (Taiwan) Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAbnova (Taiwan) Corp
Active IndicationsN/A
Inactive IndicationsInflammationNeoplasmsSepsis

Other Information

ATC CodeN/A
Related LinksN/A